Overview
No overview information available.
Indication
用于结核杆菌感染诊断，推荐用于6月龄及以上婴儿、儿童及65周岁以下成人。 本品皮试结果不受卡介苗（BCG）接种的影响，可用于辅助结核病的临床诊断。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2016/06/03 | Phase 2 | Completed | German Breast Group |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) | 国药准字S20237004 | 生物制品 | 注射剂 | 3/13/2023 | |
| Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) | 国药准字S20200006 | 生物制品 | 注射剂 | 4/23/2020 | |
| Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) | 国药准字S20200004 | 生物制品 | 注射剂 | 4/23/2020 | |
| Recombinant Mycobacterium Tuberculosis Fusion Protein(EC) | 国药准字S20200005 | 生物制品 | 注射剂 | 4/23/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.